Aramark director granted 61.449 dividend rights

Aramark (ARMK) director Kenneth M. Keverian reported an automatic acquisition of 61.449 dividend equivalent rights on September 9, 2026, tied to the company’s quarterly dividend on deferred stock units.

Rhea-AI Filing Summary

Aramark (ARMK) director Kenneth M. Keverian reported an automatic acquisition of 61.449 dividend equivalent rights on September 9, 2026, tied to the company’s quarterly dividend on deferred stock units. These rights were granted at $0.00 per right and increase his directly held common stock-equivalent position to 29,203.826 shares. The dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 61.449 shares

Grant/Award 1 txn

Insider KEVERIAN KENNETH M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	61.449	$0.00	$0.00

Holdings After Transaction: Common Stock — 29,203.826 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Key Figures

Dividend equivalent rights acquired: 61.449 rights Price per right: $0.00 per right Holdings after transaction: 29,203.826 shares +1 more

4 metrics

Dividend equivalent rights acquired 61.449 rights Grant/award acquisition on September 9, 2026

Price per right $0.00 per right Dividend equivalent rights tied to quarterly dividend

Holdings after transaction 29,203.826 shares Direct common stock-equivalent holdings after September 9, 2026 award

Transaction date September 9, 2026 Date dividend equivalent rights accrued

Key Terms

dividend equivalent rights, deferred stock units, quarterly dividend

3 terms

dividend equivalent rights financial

"Represents dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

deferred stock units financial

"accrued to the reporting person on deferred stock units held by the reporting person"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

quarterly dividend financial

"in connection with the Issuer's quarterly dividend and accrued to the reporting person"

A quarterly dividend is a payment a company gives to its shareholders four times a year, usually as a share of its profits. It's like getting a small bonus every few months for owning the company's stock, which can provide a steady income. Investors watch these payments to see how well a company is doing and whether it’s a good investment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) report for Kenneth M. Keverian?

Aramark reported that director Kenneth M. Keverian acquired 61.449 dividend equivalent rights on September 9, 2026, related to deferred stock units and the company’s quarterly dividend. These were reported as a grant or award at a price of $0.00 per right.

How many Aramark (ARMK) shares or equivalents does Kenneth M. Keverian hold after this Form 4?

Following the September 9, 2026 transaction, Kenneth M. Keverian is reported to hold 29,203.826 Aramark common stock-equivalent shares directly, including the newly accrued dividend equivalent rights tied to his deferred stock units.

What are the 61.449 rights reported for Aramark (ARMK) on this Form 4?

The 61.449 reported units are dividend equivalent rights that accrued in connection with Aramark’s quarterly dividend on deferred stock units held by Kenneth M. Keverian. According to the disclosure, these rights vest on the same schedules as the underlying deferred stock unit awards.

Was the Aramark (ARMK) insider transaction done under a Rule 10b5-1 trading plan?

No. The filing indicates no Rule 10b5-1 trading plan is reported for this transaction. The acquisition reflects dividend equivalent rights accruing automatically on deferred stock units due to Aramark’s quarterly dividend.

Did Kenneth M. Keverian buy or sell Aramark (ARMK) shares for cash in this filing?

No cash purchase or sale is reported. The Form 4 shows a grant/award acquisition of 61.449 dividend equivalent rights at $0.00 per right, arising from dividend equivalents on deferred stock units, rather than an open-market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:16 PM Accepted by SEC EDGAR 09/10/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KEVERIAN KENNETH M

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		A		61.449(1)	A	$0	29,203.826	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)